We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SACHRP Praises OHRP Adverse Event Guidance, Asks for FDA Action
SACHRP Praises OHRP Adverse Event Guidance, Asks for FDA Action
November 21, 2005
The HHS Secretary’s Advisory Committee on Human Research Protections (SACHRP) lauded a recent draft guidance on adverse event reporting at its recent meeting in Washington, D.C. SACHRP also grilled the FDA about when it could expect similar guidance from the agency.